GGrantScoutHQCreate alert

Grants for For-profit organizations other than small businesses — Page 16

Current opportunities whose structured applicant data includes For-profit organizations other than small businesses. Confirm entity definitions, geography, registrations, exclusions and every other condition in the official notice.

368 current opportunities · showing 361–368

OPENHealth & Medical

Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages grant applications to support research in cancer epidemiology cohort studies that address specific knowledge gaps in cancer etiology and survivorship. Applications should include hypothesis-based resear

Deadline
Jul 6, 2029
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)

National Institutes of Health

This notice of funding opportunity (NOFO) encourages applications for implementation of investigator-initiated, milestone driven clinical trials that need enhanced oversight, and as applicable, include mechanistic studies. Mechanistic work in clinical trials may be of great value because it promotes

Deadline
Jul 6, 2029
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) will support, through the cooperative agreement mechanism, investigator-initiated observational studies or biomarker validation studies that require prospective collection of data/biospecimens or continued analysis of data/biospecimens.

Deadline
Jul 6, 2029
Funding
Up to $500,000
Check fit and official source →
OPENHealth & Medical

Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) encourages collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution of a biomedical problem; and 2) integrate, optimize, validate, translate or otherwise accelerate the adoption of promi

Deadline
Jul 6, 2029
Funding
Up to $500,000
Check fit and official source →
OPENHealth & Medical

Academic Career Excellence (ACE) Award (K32 Independent Clinical Trial Not Allowed)

National Institutes of Health

The purpose of the Academic Career Excellence (ACE) Award (K32) is to support rigorous, mentored scientific research and career development for up to three years for early-stage postdoctoral scholars. Candidates must submit their application up to one year prior to beginning their postdoctoral posit

Deadline
Jul 13, 2029
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Limited Competition: Small Grant Program for Mentored Research Career Development Award Recipients (R03) (Clinical Trials Not Allowed)

National Institutes of Health

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) announces a program that provides NIAMS-supported K01, K08, K23, and K25 recipients the opportunity to apply for the Small Grant (R03) during the second to fourth year of their K award, as well as to provide support to

Deadline
Jul 17, 2029
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), NCI solicits applications for the Research Units (RUs), one of the two scientific components of the Pancreatic Cancer Detection Consortium (PCDC), to conduct research on early detection of pancreatic ductal adenocarcinoma (PDAC) and characterization

Deadline
Nov 6, 2029
Funding
Up to $600,000
Check fit and official source →
OPENHealth & Medical

NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of NEI's Translational Research program (TRP) is the rapid and efficient translation of innovative laboratory research findings into therapeutics for use by clinicians to treat visual system diseases or disorders. The TRP will support the product development of biological, pharmaceu

Deadline
Nov 17, 2029
Funding
See official notice
Check fit and official source →

Before you apply

Applicant type is only the first screening step. Check location, project purpose, cost share, required partners, registration lead time and the funder’s definition of an eligible entity.